"
Explanatory Variables as Evidence for Precision in Intramuscular Long-Acting Injections of Patients with Schizophrenia"
written by Shigeaki Masuda, Sakiko Sakamaki, Yuko Yasuhara, Yueren Zhao, Kensaku Takase, Yoshihiro Kai, Tetsuya Tanioka, Rozzano C. Locsin,
published by
Open Journal of Psychiatry,
Vol.6 No.1, 2016
has been cited by the following article(s):
|
[1]
|
Point-of-care ultrasound guidance for long-acting cabotegravir–rilpivirine administration improves injection-site tolerability and preserves pharmacokinetics
AIDS,
2026
DOI:10.1097/QAD.0000000000004437
|
|
|
|
|
[2]
|
Efficacy and Safety in Intramuscular Injection Techniques Using Ultrasonographic Data
Health,
2018
DOI:10.4236/health.2018.103027
|
|
|
|
|
[3]
|
Evaluations of echogenicity in gluteal muscle in patients with schizophrenia treated with second generation long-acting injectable antipsychotics: risperidone or aripiprazole
Neurosonology,
2018
DOI:10.2301/neurosonology.31.7
|
|
|
|
|
[4]
|
Effects of Depth of Needle Insertion with Risperidone Long-Acting Injectable in Persons with Schizophrenia: A Randomized Double-Blind Study
Open Journal of Psychiatry,
2017
DOI:10.4236/ojpsych.2017.74031
|
|
|
|